SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-110118
Filing Date
2024-04-24
Accepted
2024-04-24 16:15:59
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-24

Document Format Files

Seq Description Document Type Size
1 ARS d524414dars.pdf ARS 3423970
  Complete submission text file 0001193125-24-110118.txt   4717226
Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39460 | Film No.: 24870772
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)